Matthew Sims
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Nosocomial Infections in ICU 9
-
- Clostridium difficile and Clostridium perfringens research 14
- Antimicrobial Resistance in Staphylococcus 6
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Yu‐Chieh LeeMichelle BrownJiejun DuAlison PedleyAmanda PaschkeNicholas A. KartsonisPatrick McLerothRichard G. Wunderink
- Journals
- Open Forum Infectious Diseases (5 papers)Journal of Clinical Microbiology (3 papers)Radiation Research (2 papers)Gastroenterology (2 papers)Infection Control and Hospital Epidemiology (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Matthew Sims
40 papers receiving 650 citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Applied Microbiology and Biotechnology 68
- Molecular Medicine 161
- Clinical Biochemistry 84
- Critical Care and Intensive Care Medicine 58
- Infectious Diseases 197
Countries citing papers authored by Matthew Sims
This map shows the geographic impact of Matthew Sims's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Sims with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Sims more than expected).
Fields of papers citing papers by Matthew Sims
This network shows the impact of papers produced by Matthew Sims. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Sims. The network helps show where Matthew Sims may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthew Sims, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | Bile salt hydrolase acyltransferase activity expands bile acid diversity Hit paper breakdown → | 2024 | 80 |
| 5 | 2023 | 3 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 3 | |
| 10 | 2022 | 7 | |
| 11 | 2021 | 11 | |
| 12 | 2021 | 3 | |
| 13 | 2021 | 1 | |
| 14 | Multicenter Evaluation of NeuMoDx Group B Streptococcus Assay on the NeuMoDx 288 Molecular System | 2019 | 1 |
| 15 | 2017 | 126 | |
| 16 | 2013 | 19 | |
| 17 | 2012 | 30 | |
| 18 | 2011 | 13 | |
| 19 | 2010 | 12 | |
| 20 | 1991 | 15 |
About Matthew Sims
Matthew Sims is a scholar working on Critical Care and Intensive Care Medicine, Infectious Diseases, Clinical Biochemistry, Molecular Medicine and Endocrinology, having authored 42 papers that have together received 662 indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (14 papers), Nosocomial Infections in ICU (9 papers), Gut microbiota and health (8 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Bacterial Identification and Susceptibility Testing (5 papers), Pneumonia and Respiratory Infections (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Blood disorders and treatments (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (68 citations), Molecular Medicine (161 citations), Clinical Biochemistry (84 citations), Critical Care and Intensive Care Medicine (58 citations) and Infectious Diseases (197 citations). Matthew Sims has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Yu‐Chieh Lee, Michelle Brown, Jiejun Du, Alison Pedley, Amanda Paschke, Nicholas A. Kartsonis, Patrick McLeroth, Richard G. Wunderink, Fen Ma and Jeffrey D. Band. Their work appears in journals such as Open Forum Infectious Diseases, Journal of Clinical Microbiology, Radiation Research, Gastroenterology and Infection Control and Hospital Epidemiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.